Parkman Healthcare Partners LLC Portfolio Holdings

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

Parkman Healthcare Partners LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $708 Million distributed in 93 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $37.5M, Insulet Corp with a value of $37.2M, Eli Lilly & CO with a value of $35.8M, Keros Therapeutics, Inc. with a value of $24.5M, and Teleflex Inc with a value of $23.8M.

Examining the 13F form we can see an increase of $30.4M in the current position value, from $678M to 708M.

Parkman Healthcare Partners LLC is based out at Stamford, CT

Below you can find more details about Parkman Healthcare Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $708 Million

Healthcare: $703 Million

Industrials: $5.39 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LLY Eli Lilly & CO Healthcare	$711B	$35.8 Million 5.05% of portfolio	40,384	Q3 2024 Added 27.58%
ABT Abbott Laboratories Healthcare	$206B	$14.1 Million 1.99% of portfolio	123,601	Q3 2024 Added 1.38%

Summary

Portfolio
No. of Stocks 93
Current Value $708 Million
Prior Value $678 Million
Filing
Period Q3 2024
Filing Date November 14, 2024
Form Type 13F-HR
Activity in Q3 2024
New Purchases 16 stocks
Additional Purchases 38 stocks
Sold out of 0 stocks
Reduced holdings in 39 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Portfolio Holdings